Dr. Matthew L. Ryan
Claim this profileSaint Vincent Hospital Cancer Center Green Bay
Expert in Cancer
Studies Recurrence
45 reported clinical trials
103 drugs studied
About Matthew L. Ryan
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Internal Medicine at a hospital affiliated with the University of Wisconsin School of Medicine and Public Health.
- Undertook a Fellowship in Hematology/Oncology at the University of Wisconsin Carbone Cancer Center.
Experience:
- Currently practices as a hematologist and oncologist at Saint Vincent Hospital Cancer Center in Green Bay.
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Matthew L. Ryan is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Nivolumab + Standard Treatment
for Stomach and Esophageal Cancer
This phase II/III trial compares the addition of nivolumab to the usual treatment of paclitaxel and ramucirumab to paclitaxel and ramucirumab alone in treating patients with gastric or esophageal adenocarcinoma that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Adding nivolumab to ramucirumab and paclitaxel may work better to treat patients with advanced stomach or esophageal cancer.
Recruiting1 award Phase 2 & 320 criteria
More about Matthew L. Ryan
Clinical Trial Related1 year of experience running clinical trials · Led 45 trials as a Principal Investigator · 27 Active Clinical TrialsTreatments Matthew L. Ryan has experience with
- Atezolizumab
- Paclitaxel
- Cisplatin
- Pembrolizumab
- Nivolumab
- Radiation Therapy
Breakdown of trials Matthew L. Ryan has run
Cancer
Recurrence
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew L. Ryan specialize in?
Matthew L. Ryan focuses on Cancer and Recurrence. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Matthew L. Ryan currently recruiting for clinical trials?
Yes, Matthew L. Ryan is currently recruiting for 26 clinical trials in Green Bay Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Matthew L. Ryan has studied deeply?
Yes, Matthew L. Ryan has studied treatments such as Atezolizumab, Paclitaxel, Cisplatin.
What is the best way to schedule an appointment with Matthew L. Ryan?
Apply for one of the trials that Matthew L. Ryan is conducting.
What is the office address of Matthew L. Ryan?
The office of Matthew L. Ryan is located at: Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin 54301 United States. This is the address for their practice at the Saint Vincent Hospital Cancer Center Green Bay.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.